Skip to main content

Therapeutic Equivalency

5
Pipeline Programs
2
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
5
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
5 programs
5
FesoterodinePhase 11 trial
etynodiol diacetatePhase 11 trial
methylprednisolonePhase 11 trial
methylprednisolonePhase 11 trial
methylprednisolonePhase 11 trial
Active Trials
NCT00807118Completed108Est. Dec 2008
NCT01359163Completed20Est. Jul 2011
NCT01405131Withdrawn0Est. Feb 2012
+2 more trials
Black Diamond Therapeutics
1 program
Azathioprine 50Mg TabPHASE_11 trial
Active Trials
NCT03930264Completed30Est. May 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Black Diamond TherapeuticsAzathioprine 50Mg Tab
Pfizermethylprednisolone
Pfizermethylprednisolone
Pfizermethylprednisolone
Pfizeretynodiol diacetate
PfizerFesoterodine

Clinical Trials (6)

Total enrollment: 158 patients across 6 trials

Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)

Start: Apr 2019Est. completion: May 201930 patients
Phase 1Completed
NCT01405131Pfizermethylprednisolone

A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets

Start: Jan 2012Est. completion: Feb 20120
Phase 1Withdrawn
NCT01405157Pfizermethylprednisolone

A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions

Start: Jan 2012Est. completion: Feb 20120
Phase 1Withdrawn
NCT01405170Pfizermethylprednisolone

A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions

Start: Oct 2011Est. completion: Feb 20120
Phase 1Withdrawn
NCT01359163Pfizeretynodiol diacetate

A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects

Start: Jun 2011Est. completion: Jul 201120 patients
Phase 1Completed
NCT00807118PfizerFesoterodine

Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect

Start: Oct 2008Est. completion: Dec 2008108 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.